Special Issue "Antivirals"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: 30 September 2010

Special Issue Editor

Guest Editor
Prof. Dr. Ulrich Jordis
Institute of Applied Synthetic Chemistry, Vienna University of Technology, Getreidemarkt 9/163, A-1060 Wien, Austria
Website: http://phoenix.tuwien.ac.at/
E-Mail:
Interests: antivirals; Alzheimer; quinolones; combinatorial chemistry; labelled compounds; natural products (alkaloids; triterpenes); custom synthesis; chemistry software and databases

Published Papers

No papers have been published in this special issue yet.

Special Issue Information

Related Special Issue

Antivirals
in Molecules.

Dear Colleagues,

Molecules and Pharmaceuticals, being pioneer journals of web-based publications, invites you to submit research articles and comprehensive reviews addressing the discovery and/or development of antiviral agents in animals and man as well as in plants or lower organisms. Despite the tremendous successes and hallmarks e.g. in treating AIDS, clearly there is an ongoing and increased challenge to cope with the evolutionary and constantly changing threats of viral infections that have even the potential to ultra-risks for the mankind. Natural products continue to provide important leads and structures for the development of antiviral compounds and insights into the biochemical pathways and cell live cycles provide new starting points for new antiviral mechanisms. This issue intends to delineate the efforts being made to develop new and effective broad-spectrum antiviral agents e.g. for the treatment of HSV, VZV, HIV, HBV and DNA virus infections.

Prof. Dr. Ulrich Jordis
Guest Editor

Submission

All manuscripts should be submitted to pharmaceuticals@mdpi.org with a copy to the Guest Editor. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. Article Processing Charges (APC) for publication in this Open Access journal will be waived for well-prepared manuscripts submitted before 30 June 2010. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.

Last update: 17 March 2010

Pharmaceuticals EISSN 1424-8247 Published by MDPI Publishing, Basel, Switzerland RSS E-Mail Table of Contents Alert